Literature DB >> 27055814

Risk factors for heart failure are associated with alterations of the LV end-diastolic pressure-volume relationship in non-heart failure individuals: data from a large-scale, population-based cohort.

Michael Schwarzl1, Francisco Ojeda2, Tanja Zeller3, Moritz Seiffert2, Peter M Becher2, Thomas Munzel4, Philipp S Wild4, Maria Blettner5, Karl J Lackner6, Norbert Pfeiffer7, Manfred E Beutel8, Stefan Blankenberg3, Dirk Westermann3.   

Abstract

AIMS: Left-ventricular (LV) remodelling impacts on the LV end-diastolic pressure-volume relationship (EDPVR), which is different in heart failure (HF) with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF). In a large-scale, population-based cohort (Gutenberg Health Study), we aimed to investigate alterations of the EDPVR in HF patients and their association to risk factors and all-cause mortality in non-HF individuals. METHODS AND
RESULTS: Based on clinical and echocardiographic data, participants were divided into 'No HF' (n = 14487), HFrEF (n = 215), and HFpEF (n = 79). We estimated the position of the EDPVR and its stiffness-coefficient β from echocardiographic data using a single-beat method. The EDPVR was shifted rightward in HFrEF and leftward in HFpEF compared with 'No HF', while the stiffness-coefficient β was increased in both HFrEF and HFpEF. In 'No HF', a higher stiffness-coefficient β was associated with age, female gender, hypertension, diabetes, and obesity, while age and female gender were associated with a leftward shift of the EDPVR, whereas dyslipidaemia, obesity, smoking, and impaired renal function were associated with a rightward shift of the EDPVR. Both changes of the EDPVR were associated with increased all-cause mortality.
CONCLUSION: In a large-scale, population-based cohort, we show distinct alterations of the EDPVR in HFrEF and HFpEF. Already in non-HF individuals, the presence of risk factors for HF is linked alterations of the EDPVR, which are associated with increased mortality. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Diastolic function; Heart failure; Population-based study; Pressure–volume relationship; Risk factor

Mesh:

Substances:

Year:  2016        PMID: 27055814     DOI: 10.1093/eurheartj/ehw120

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  18 in total

1.  The relationships between the pulsatile flow form of ocular microcirculation by laser speckle flowgraphy and the left ventricular end-diastolic pressure and mass.

Authors:  Tomoaki Shiba; Mao Takahashi; Chieko Shiba; Tadashi Matsumoto; Yuichi Hori
Journal:  Int J Cardiovasc Imaging       Date:  2018-06-01       Impact factor: 2.357

2.  Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients.

Authors:  Christoph Sinning; Francisco Ojeda; Philipp S Wild; Renate B Schnabel; Michael Schwarzl; Sevenai Ohdah; Karl J Lackner; Norbert Pfeiffer; Matthias Michal; Maria Blettner; Thomas Munzel; Tibor Kempf; Kai C Wollert; Kari Kuulasmaa; Stefan Blankenberg; Veikko Salomaa; Dirk Westermann; Tanja Zeller
Journal:  Clin Res Cardiol       Date:  2016-12-21       Impact factor: 5.460

3.  Change of Left Ventricular Geometric Pattern in Patients with Preserved Ejection Fraction Undergoing Coronary Artery Bypass Grafting.

Authors:  Han Wang; Bing Zhang; Wei-Chun Wu; Zhen-Hui Zhu; Hao Wang
Journal:  J Cardiovasc Transl Res       Date:  2022-05-11       Impact factor: 4.132

Review 4.  Expert proposal to characterize cardiac diseases with normal or preserved left ventricular ejection fraction and symptoms of heart failure by comprehensive echocardiography.

Authors:  A Hagendorff; A Helfen; R Brandt; E Altiok; O Breithardt; D Haghi; J Knierim; D Lavall; N Merke; C Sinning; S Stöbe; C Tschöpe; F Knebel; S Ewen
Journal:  Clin Res Cardiol       Date:  2022-06-04       Impact factor: 5.460

Review 5.  Diagnostic role of echocardiography for patients with heart failure symptoms and preserved left ventricular ejection fraction.

Authors:  A Hagendorff; S Stöbe; J Kandels; R de Boer; C Tschöpe
Journal:  Herz       Date:  2022-05-02       Impact factor: 1.740

6.  Left Ventricular Diastolic Myocardial Stiffness and End-Diastolic Myofibre Stress in Human Heart Failure Using Personalised Biomechanical Analysis.

Authors:  Zhinuo J Wang; Vicky Y Wang; Chris P Bradley; Martyn P Nash; Alistair A Young; J Jane Cao
Journal:  J Cardiovasc Transl Res       Date:  2018-07-11       Impact factor: 4.132

7.  Distribution of estimated glomerular filtration rate and determinants of its age dependent loss in a German population-based study.

Authors:  Thomas Waas; Andreas Schulz; Johannes Lotz; Heidi Rossmann; Norbert Pfeiffer; Manfred E Beutel; Irene Schmidtmann; Thomas Münzel; Philipp S Wild; Karl J Lackner
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

8.  Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction.

Authors:  Grazia Esposito; Donato Cappetta; Rosa Russo; Alessia Rivellino; Loreta Pia Ciuffreda; Fiorentina Roviezzo; Elena Piegari; Liberato Berrino; Francesco Rossi; Antonella De Angelis; Konrad Urbanek
Journal:  Br J Pharmacol       Date:  2017-03-21       Impact factor: 8.739

9.  Reduced left ventricular contractility, increased diastolic operant stiffness and high energetic expenditure in patients with severe aortic regurgitation without indication for surgery.

Authors:  Jan-Christian Reil; Gert-Hinrich Reil; Nora Hecker; Vasco Sequeira; Jeffrey S Borer; Ulrich Stierle; Daniel Lavall; Christoph Marquetand; Claudia Busch; Johannes Patzelt; Matthias Heringlake; Hans-Joachim Schäfers; Hans-Hinrich Sievers; Stephan Ensminger; Anas Aboud
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-01-01

10.  Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction.

Authors:  Liyun Zhang; Juan Chen; Lianhua Yan; Qin He; Han Xie; Manhua Chen
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.